Digital Events | Kisaco Research
Filter by:
Pandemic Prevention and Innovation Summit
9 Mar 2021
Virtual Summit
In light of the current Covid-19 pandemic, join us on March 1, 2021 for the inaugural Pandemic Prevention & Innovation Summit as we bring together leading figures from the private, public, philanthropic & civil service sectors to participate in open discussion focused on how we can be better prepared for future pandemics through innovative technology & therapeutics.Discover new fields for viable investment in the infectious disease space through an expert lens, as they identify areas of innovation which have been successful in past pandemic responses & new areas which could see disruption in future pandemic responses.During the summit, learn of global collaborative initiatives promoting the development of R&D in pandemic preparedness. Following the interactive sessions, identify solution providers from the attendee list for your unique organisation needs & simply connect with them through our private meeting scheduler, available to all participants. Finally, get the chance to participate in exclusive interactive discussions led by key speakers, including representatives from the WHO & Council on Strategic Risks.
Animal Microbiome Congress 2021
24-25 Mar 2021
Virtual Event
Animal Microbiome Congress will provide the latest clinical data and key content on the commercialisation of animal microbiome research. The global market is forecasted to grow to $9,775 million by 2028 due to demand for innovation from the rapidly growing meat and pet-healthcare industries. Research indicates that animal microbiome modulation could greatly improve pet health and increase the meat industry’s productivity, while ensuring that it meets its sustainability targets. Consequently, significant profits can be created by overcoming the obstacles in reproducing animal microbiome research in industry and quicker returns can be obtained by translating the more advanced human microbiome technology to modulate the animal microbiome. However, these commercial rewards can only be realised by steering through tough legal obstacles smartly. Our goal is to support smart interactions between business and academia to enable participants to capitalize on the growing global animal microbiome market.
Filter by:
Microbiome Connect - Skin - EU 2020
10-11 Nov 2020
2019 proved to be a pivotal year for the skin microbiome, as personal care giants Unilever launched their Dove range of ‘microbiome-friendly’ skincare products. Clearly, the biggest players in beauty and personal care have recognised the potential commercial value of skin microbiome-based consumer product claims and formulations. Moving forward into 2021, the market will continue to see more and more products launched with microbiome claims backed through next-generation sequencing techniques. Including ingestible beauty products that influence the gut-skin axis, to truly personalized skincare solutions and mass market formulations – there’s a huge commercial opportunity to commercialise skin microbiome research into consumer care products. So, what’s different at Microbiome Connect: Skin EU Virtual? Six new topics to explore:The skin-gut axis and the development of ingestible beauty products.Personalisation of skin-microbiome products and formulation considerations.Defining skin-microbiome industry terminology and developing scientifically backed claims that resonate with consumers.Next generation sequencing techniques and their application in claims development.New data demonstrating the role of the microbiome in common skin conditions including acne, eczema and dandruff.The vaginal and oral microbiomes and the mass market product development opportunities to treat gingivitis/periodontitis and sexually transmitted infections.
Microbiome Connect : Human - USA 2020
3-5 Jun 2020
The gut microbiome is becoming an increasingly important druggable target for pharma companies through a range of modalities from FMT to small molecule and even phage. 2020 looks set to be a pivotal year for the microbiome industry with a handful of companies (including Seres, Rebiotix and Finch Therapeutics) set to release ground-breaking phase 3 clinical data. We’re a step away from market approval, but there’s still so much to learn…Major advances in shotgun metagenomic sequencing and computational biology allow us to see what’s going on at a strain-specific and metabolomic level of detail. Elucidating the key metabolites and mechanisms of action in both extra-intestinal and intestinal indications is a key objective in 2020/2021 and is a cornerstone of the discussion at Microbiome Connect: Human. Join key opinion leaders to examine the latest preclinical and clinical data in extra-intestinal and intestinal indications. This is your opportunity to translate gut-microbiome research into therapeutics that have the power to treat oncological, neurological, gastro-intestinal & metabolic diseases.Previously known as North American Microbiome Congress, Microbiome Connect: Human USA is all about connecting leading academics and biotech companies presenting preclinical and clinical data, to network, educate and share knowledge. 
Microbiome Connect - Skin - USA 2020
3-5 Jun 2020
2019 was a pivotal year for the skin microbiome, with multinational conglomerates moving into the space, recognizing the commercial value of skin microbiome-based products as the next step in a consumer’s skincare regime but the innovation doesn’t end there…This year is all about the major advancements of sequencing and analysis in this space, and how we can use data to inform product development. 2020 is all about the relationship between skin microbiome based-products, skin conditions, personalization, skin-gut supplements, and anti-aging. Building on the hugely successful global Skin Microbiome series which brought together over 600 industry leaders from Pharmaceutical, Beauty and Personal Care, Independent Skincare Brands, Bio-techs, Researchers and Academics, Kisaco Research presents Microbiome Connect: Skin USA, an all-encompassing event, which runs alongside Microbiome Connect: Human USA as a virtual event, June 3 - 5.What’s different?This year, you can expect 5 unique topics, more attendees and more networking opportunities to explore:Ground-breaking research into how best treat these skin diseases and develop treatments targeting acne vulgaris, atopic dermatitis, psoriasis Vulgaris and rosacea.The translation and commercialization of product claims, the latest trends and protecting your intellectual property.The convergence between the skin-gut axis and the supplement market.Personalized formulation and product developmentTools to increase product claims using sequencing and bioinformatics.Join key opinion leaders and expert speakers across three days to translate the latest skin microbiome data and market analysis into truly commercial and competitive beauty and personal care products.Skin microbiome based-products have been disrupting the beauty industry for the past two years, the question is, how can you differentiate your products?

Contact Us to Find Out More